.jpg)
To focus on molecules at advanced stage of development; move to impact 200 scientists.
Wockhardt MD Murtaza Khorakiwala said his firm had responded to the FDA's observations but declined to give details.
The Indian Pharmaceutical Alliance has approached regulator for a dialogue to understand the concern raised by it
This is not just a Ranbaxy or Wockhardt problem, says K Satish Reddy
"Due to scheduling reasons, it is inconvenient for China to attend the meeting," Chinese Foreign Ministry spokesman Wang Wenbin told mediapersons.
In 2014, Sun Pharma agreed to buy Ranbaxy -- which was then controlled by Daiichi.
Test reports from UP food regulator started the controversy.
The company buys distressed assets across the globe and turns them around to not only add to its books but also its product pipeline and regions.
The under-one-minute films are titled 'Menu Cards, Mom and Neighbours'.
Of the 30-share Sensex pack, 22 ended with losses while NTPC ended flat at Rs 127.30.
Gujarat has around 3,000 licensees for allopathic drug manufacturing, apart from around seven homeopathic licensees, 500 ayuvedic and 600-700 cosmetics licensees
Roadshows will be held in Singapore, Hong Kong, London, New York and Boston, NTPC gained close to 1%.
Inspections only in domestic authorities' presence, visiting US drug regulator told
The Competition Commission of India and the US Federal Trade Commission are yet to give their nod to the biggest pharma merger and acquisition deal this year in the Asia-Pacific region.
The global heath body had earlier suspended the hydroxychloroquine arm of the clinical trials of experimental COVID-19 drugs over safety concerns.
Elizabeth Holmes founded Theranos in 2003 and it promised ground-breaking methods that would allow quick results for a wide range of tests with just one drop of blood.
Pharma was the top losing index amid worries about their earnings outlook with Lupin down over 4%
4 Ranbaxy facilities in India have been barred from exporting to US.
Its Waluj manufacturing facility in Maharashtra failed to meet the good manufacturing norms prescribed by the UK drug regulator.
South-east Asian countries are emerging as preferable destination for India's pharma companies to expand their business as they share similar patient population and disease profile and moreover, have a conducive environment for their operations like easy market approach without any regulatory uncertainty, the survey of Indian pharma firms highlighted.
Researchers claim to have developed a new treatment for ovarian cancer that can increase the rate of tumour shrinkage and prolong the time until cancers recur.
'The focus for value creation will be on all business segments.'
Asset valuation consultancy sees brand value slip to $2.2 billion.
Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on the coronavirus vaccines in India.
Patanjali's packet milk to be lower than competitor brands by Rs 2 a litre
The joint entity will have a market share of nine per cent in India. Analysts tracking the company said one of the key outcomes of the merger would be to create a single brand entity of Sun and the Ranbaxy brand would eventually dissolve.
A look at the top tweets from your favourite Bollywood celebrities.
The government plans to rationalise trade margins for many other medical devices, besides stents and knee implants.
Five days after the induction of 18 ministers into his cabinet, Maharashtra Chief Minister Eknath Shinde on Sunday allocated portfolios, keeping Urban Development and 11 other ministries with himself, while giving the crucial Home Department to Deputy CM Devendra Fadnavis.
The S&P BSE Sensex surged 217 points to end at 25,736.
Maggi re-entered the market on November 9.
'The Centre and state need to take a unified approach and take concerted action before this matter assumes menacing proportions because unemployment, the drug trade and the levels of frustration among the youth make them vulnerable to any maverick who promises something better.'
GE Healthcare has already filed five global patents for its design.
The Ranbaxy experience has made multinational corporations more cautious about Indian acquisitions in general
An International Policy Network report in 2010 found that seven per cent of drugs bought from wholesale traders were substandard, and 3.6 per cent of the drugs from traders contained no active ingredient whatsoever.
Vice President Mike Pence said Trump had authorised a ban on entry of foreign nationals who travelled to Iran in the last 14 days. The United States also advised its citizens not to travel to parts of South Korea and Italy, from where reports of coronavirus have appeared.
Broader market outperformed with the S&P BSE Midcap index adding 0.7%, while S&P BSE Smallcap index gained 0.6%.
Instant noodle from Nestle is not the first food brand in India to have faced a tough time though
'Nobody is attacking the company or the vaccine.' 'The concerns are about the process and the lack of transparency.'
There are a number of vaccine candidates already in clinical trial and a few out of those candidates have completed phase 1/2 status, he said, adding that there are trials that will be going into phase three sometime at the end of July and then others will follow in the months of August, September and October.
